112.84
前日終値:
$112.28
開ける:
$112.63
24時間の取引高:
42,129
Relative Volume:
0.04
時価総額:
$6.47B
収益:
$360.35M
当期純損益:
$-149.57M
株価収益率:
-38.12
EPS:
-2.96
ネットキャッシュフロー:
$-81.27M
1週間 パフォーマンス:
+0.12%
1か月 パフォーマンス:
+4.17%
6か月 パフォーマンス:
+11.41%
1年 パフォーマンス:
-27.82%
Glaukos Corporation Stock (GKOS) Company Profile
GKOS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
GKOS
Glaukos Corporation
|
112.69 | 6.45B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
127.01 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.50 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
365.06 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.71 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.68 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-27 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-10-01 | 開始されました | Goldman | Buy |
| 2025-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | アップグレード | Mizuho | Neutral → Outperform |
| 2024-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2024-12-06 | 開始されました | UBS | Buy |
| 2024-12-02 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-05-06 | アップグレード | Jefferies | Hold → Buy |
| 2023-12-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-12-04 | 開始されました | Morgan Stanley | Equal-Weight |
| 2023-11-28 | 開始されました | Truist | Buy |
| 2023-11-08 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-19 | アップグレード | JP Morgan | Underweight → Neutral |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-10-14 | 再開されました | Stephens | Overweight |
| 2022-10-04 | 開始されました | Needham | Buy |
| 2022-07-12 | アップグレード | Stifel | Hold → Buy |
| 2022-02-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | アップグレード | BTIG Research | Neutral → Buy |
| 2021-11-03 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-07-14 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | アップグレード | Citigroup | Sell → Neutral |
| 2020-12-09 | 開始されました | Oppenheimer | Perform |
| 2020-11-17 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-06-15 | 開始されました | Jefferies | Hold |
| 2020-03-05 | 開始されました | Citigroup | Sell |
| 2020-02-28 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-01-06 | アップグレード | Berenberg | Hold → Buy |
| 2019-12-12 | ダウングレード | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | 開始されました | BTIG Research | Neutral |
| 2018-08-30 | 開始されました | Berenberg | Hold |
| 2018-08-29 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-08-03 | 繰り返されました | Stifel | Hold |
| 2018-06-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2018-04-13 | ダウングレード | Stifel | Buy → Hold |
| 2018-03-01 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2017-03-02 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2017-01-06 | アップグレード | Stifel | Hold → Buy |
| 2016-10-27 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Glaukos Corporation (GKOS) 最新ニュース
Will Glaukos Corporation stock gain from government policies2026 world cup usa national team round of 32 defensive leaders low block defense expert forecast guide - Улправда
Glaukos Corporation's (NYSE:GKOS) Shift From Loss To Profit - simplywall.st
Glaukos approved for $14M Alabama tax credit - Lagniappe Daily
Block Trades: How geopolitical risks impact Glaukos Corporation 6GJ stockWeekly Profit Report & Capital Efficient Trade Techniques - moha.gov.vn
Allspring Global Investments Holdings LLC Sells 13,317 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation (NYSE:GKOS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Glaukos Corporation (NYSE:GKOS): Are Analysts Optimistic? - Yahoo Finance
Glaukos price target raised to $145 from $115 at Stephens - Yahoo Finance
Glaukos (NYSE:GKOS) Given Buy Rating at BTIG Research - MarketBeat
Glaukos stock maintains Buy rating at BTIG on Epioxa launch potential - Investing.com
Glaukos stock maintains Buy rating at BTIG on Epioxa launch potential By Investing.com - Investing.com Nigeria
Avoiding Lag: Real-Time Signals in (GKOS) Movement - Stock Traders Daily
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now - Finviz
Harbor Capital Advisors Inc. Decreases Stake in Glaukos Corporation $GKOS - MarketBeat
Glaukos price target raised to $125 from $113 at Citi - MSN
Glaukos Corp (NYSE:GKOS) Shares Rise After Quarterly Results - Kalkine Media
Glaukos Corporation $GKOS Shares Purchased by Voya Investment Management LLC - MarketBeat
UBS Maintains Glaukos (GKOS) Buy Recommendation - Nasdaq
J.P. Morgan Healthcare Conference - marketscreener.com
Glaukos Corporation $GKOS Shares Purchased by Riverbridge Partners LLC - MarketBeat
Glaukos Corporation $GKOS Shares Sold by Texas Permanent School Fund Corp - MarketBeat
Why Glaukos Corporation (6GJ) stock is listed among top recommendations2025 Fundamental Recap & Target Return Focused Picks - Улправда
EBIT per share of Glaukos Corp – DUS:6GJ - TradingView — Track All Markets
Assenagon Asset Management S.A. Has $12.85 Million Stock Holdings in Glaukos Corporation $GKOS - MarketBeat
Technical Reactions to GKOS Trends in Macro Strategies - Stock Traders Daily
What valuation multiples suggest for Glaukos Corporation stockJuly 2025 Spike Watch & Daily Stock Trend Reports - Улправда
How Glaukos Corporation stock benefits from strong dollar2025 Growth vs Value & Weekly High Conviction Ideas - DonanımHaber
Can Glaukos Corporation stock resist market sell offsJuly 2025 Fed Impact & Free Reliable Trade Execution Plans - DonanımHaber
How Glaukos Corporation stock compares to industry benchmarksJuly 2025 Spike Watch & Daily Volume Surge Signals - DonanımHaber
Is Glaukos Corporation stock positioned for digital transformationJuly 2025 Intraday Action & Stock Portfolio Risk Control - ulpravda.ru
Will Glaukos Corporation stock outperform growth indexesJuly 2025 Trade Ideas & Weekly High Return Forecasts - Улправда
Market Overview: Is Glaukos Corporation stock positioned for digital transformationPortfolio Risk Report & Low Risk Profit Maximizing Plans - Улправда
February 2026 Options Now Available For Glaukos (GKOS) - Nasdaq
Truist Financial Issues Positive Forecast for Glaukos (NYSE:GKOS) Stock Price - MarketBeat
Truist Securities Adjusts Price Target on Glaukos Corp to $145 From $120, Maintains Buy Rating - marketscreener.com
Piper Sandler reiterates Overweight rating on Glaukos stock as 2026 top pick By Investing.com - Investing.com South Africa
Piper Sandler reiterates Overweight rating on Glaukos stock as 2026 top pick - Investing.com Nigeria
Glaukos breaks ground on high-tech facility in Alabama, eyes 150 jobs - Alabama Weather Network
Glaukos Announces Participation in J.P. Morgan Healthcare Conference - BioSpace
Revenue per share of Glaukos Corp – GETTEX:6GJ - TradingView — Track All Markets
Glaukos (NYSE: GKOS) joins 44th J.P. Morgan Healthcare Conf Jan. 13 - Stock Titan
Glaukos (GKOS): Reassessing Valuation After Citigroup’s Rating Update and iDose TR Commercial Launch - simplywall.st
Glaukos (NYSE: GKOS) CEO reports new performance-based RSUs and options - Stock Titan
Glaukos (GKOS) President & COO earns 7,316 stock options after goals met - Stock Titan
Glaukos Corporation (NYSE: GKOS) discloses CFO earning 3,660 stock options - Stock Titan
Glaukos Corp (GKOS) CDO Earns 2,054 Performance-Based Shares in 2025 - Stock Titan
Stifel reiterates Buy rating on Glaukos stock, maintains $115 price target - Investing.com Nigeria
Glaukos price target raised to $125 from $117 at Needham - MSN
Glaukos Corporation $GKOS Shares Purchased by Holocene Advisors LP - MarketBeat
Gilder Gagnon Howe & Co. LLC Decreases Position in Glaukos Corporation $GKOS - MarketBeat
Eventide Asset Management LLC Sells 70,181 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation (GKOS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):